How are miscarriages discussed on social media?

Publication
Article
Contemporary OB/GYN JournalVol 65 No 05
Volume 65
Issue 05

Miscarriages and preterm birth (PTB) can be a difficult experience for expectant mothers, and many seek out positive support systems to help cope. As the world has become more digital, social media has become a support system for women who have experienced these events, according to new research published in Paediatric and Perinatal Epidemiology.

The study aimed to better understand how Twitter users discuss the topics of miscarriage and PTB, analyze the trends and drivers, and describe the perceived emotional state of women who have experienced a miscarriage.

The authors obtained 291,443 Twitter posting on miscarriages and preterm births from January 2017 through December 2018. They applied Latent Dirichlet Allocation (LDA) to identify major topics in the data. LDA models are used for uncovering latent topics within a large set of text.

Words are assigned weights within particular topics given assumed probability distributions. The authors also used time series decomposition methods to assess temporal trends and identify major conversation drivers. In order to determine the emotional content of 7282 personal miscarriage disclosure tweets, the authors classified the tweets into six non-mutually exclusive categories: grief/sadness/depression, anger, relief, isolation, annoyance, and neutral. 

Based on their findings, the authors discovered that the topics in their data fell into eight groups: celebrity disclosures, Michelle Obama’s disclosure, politics, healthcare, preterm births, loss and anxiety, flu vaccine and ectopic pregnancies.

However, they noted that the political discussions around miscarriages were largely a result of a misunderstanding between abortions and miscarriages. Within miscarriage disclosures, grief and annoyance were the emotions most commonly expressed by users 50.6% (95%CI 49.1 – 52.2) and 16.2% (95% CI 15.2 to 17.3), respectively.

The authors also noted that postings increased with celebrity disclosures; celebrities were considered strong and brave for publicly discussing the topic and Michelle Obama’s disclosure generated substantial response. These celebrity disclosures also led to increased disclosures by women who had similar experiences.

For example, Obama’s disclosure resulted in a response approximately 3.6 times higher than the weekly average of postings in 2018. Postings also increased with pharmacists’ refusal of prescribed medications and with outrage over the high rate of preterm births in the United States.

Based on the results of their study, the authors believe that celebrity disclosures lead to the biggest increase in discussions of miscarriage on social media. They also believe that the results provide an insight of current public perceptions of miscarriage and illustrate how individuals use Twitter to share information and/or seek support.

A better understanding of how individuals who have experienced miscarriage use social media may be informative for clinicians who provide miscarriage care and treatment. 

References:

Cesare, N., Oladeji, O., Ferryman, K., Wijaya, D., Hendricks, Muñoz, K. D., Ward, A., & Nsoesie, E. O. (2020). Discussions of miscarriage and preterm births on Twitter. Paediatr. Perinat. Epidemiology. doi: 10.1111/ppe.12622

Related Videos
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Unlocking the power of oxytocin | Image credit: drannacabeca.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.